Subscribe
Activist who campaigned for Honeywell’s break-up expects its parts to be worth much more than its whole
The company’s turnaround progress is slow but will reward patient investors
The company’s strong performance came while its fast food rivals have struggled
Pharma’s AI investment fits far better into the industry’s business model
The Analyst: Robin Hardy outlines the best options in a booming sector
The Squeeze: The company thinks it’s at the forefront of innovation, but it’s cutting R&D spending
Find out which stocks top fund managers think are the best in the world
There has been a rotation towards ‘real-world’ stocks as investors look to hide from AI disruption
Despite increasing profits, its free cash flow could turn negative this year
Gold becoming the go-to reserve asset and the US happy with a weaker dollar leaves the door open for shares to rise
